Tango Therapeutics, Inc.
TNGX
17 insider filings · Latest: Jun 19, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2025 | Sep 8 9:22 PM | Third Rock Ventures IV, L.P. | Proposed Sale | 86,459 | $7.04 | $608.6K | — | View → |
| Sep 5, 2025 | Sep 5 10:08 PM | Third Rock Ventures IV, L.P. | Proposed Sale | 642,906 | $6.94 | $4.5M | — | View → |
| Aug 22, 2025 | Aug 22 9:26 PM | Third Rock Ventures IV, L.P. | Proposed Sale | 302,194 | $6.90 | $2.1M | — | View → |
| Aug 19, 2025 | Aug 19 11:25 PM | Third Rock Ventures IV, L.P. | Proposed Sale | 1,100,000 | $6.96 | $7.7M | — | View → |
| Nov 6, 2024 | Nov 7 2:40 AM | Boxer Capital Management, LLC | Proposed Sale | 3,080,000 | $5.18 | $16.0M | — | View → |
| Oct 25, 2024 | Oct 26 1:30 AM | Boxer Capital Management, LLC | Proposed Sale | 633,000 | $6.29 | $4.0M | — | View → |
| Oct 22, 2024 | Oct 23 12:50 AM | Boxer Capital Management, LLC | Proposed Sale | 250,000 | $7.15 | $1.8M | — | View → |
| Oct 21, 2024 | Oct 22 4:03 PM | Boxer Capital Management, LLC | Proposed Sale | 625,000 | $7.46 | $4.7M | — | View → |
| Sep 13, 2024 | Sep 13 9:43 PM | Third Rock Ventures IV, L.P. | Proposed Sale | 67,400 | $10.50 | $707.7K | — | View → |
| Sep 5, 2024 | Sep 5 9:01 PM | Third Rock Ventures IV, L.P. | Proposed Sale | 75,000 | $11.68 | $876.0K | — | View → |
| Aug 30, 2024 | Aug 30 9:24 PM | Third Rock Ventures IV, L.P. | Proposed Sale | 175,000 | $11.83 | $2.1M | — | View → |
| Aug 27, 2024 | Aug 27 8:53 PM | Third Rock Ventures IV, L.P. | Proposed Sale | 25,000 | $11.40 | $285.0K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 19, 2026 | Jun 23 10:10 PM | Robert AzelbyDirector | Grant/Award | 35,910 | $27.97 | 35,910(D) | View → |
| Jun 5, 2026 | Jun 8 10:08 PM | John B KetchumDirector | Grant/Award | 25,000 | $20.22 | 25,000(D) | View → |
| Jun 5, 2026 | Jun 8 10:01 PM | Lesley Ann CalhounDirector | Grant/Award | 25,000 | $20.22 | 25,000(D) | View → |
| Jun 5, 2026 | Jun 8 9:55 PM | Mace RothenbergDirector | Grant/Award | 25,000 | $20.22 | 25,000(D) | View → |
| Jun 5, 2026 | Jun 8 9:49 PM | Sung LeeDirector | Grant/Award | 3,570 | $20.22 | 3,570(D) | View → |
| Jun 1, 2026 | Jun 3 10:37 PM | Adam CrystalPresident, R&D | Option Exercise | 27,000 | $5.20 | 341,040(D) | View → |
| May 1, 2026 | May 5 11:47 PM | Adam CrystalPresident, R&D | Option Exercise | 27,000 | $5.20 | 368,040(D) | View → |
| May 1, 2026 | May 5 11:46 PM | Matthew GallChief Financial Officer | Grant/Award | 240,000 | $20.98 | 240,000(D) | View → |
| Apr 29, 2026 | May 1 9:26 PM | Sung LeeDirector | Grant/Award | 5,200 | $22.06 | 5,200(D) | View → |
| Apr 15, 2026 | Apr 17 12:14 AM | Adam CrystalPresident, R&D | Option Exercise | 38,460 | $5.20 | 395,040(D) | View → |
| Apr 1, 2026 | Apr 3 12:09 AM | Adam CrystalPresident, R&D | Option Exercise | 27,000 | $5.20 | 433,500(D) | View → |
| Mar 25, 2026 | Mar 28 12:06 AM | Adam CrystalPresident, R&D | Option Exercise | 12,000 | $5.20 | 460,500(D) | View → |
| Feb 2, 2026 | Feb 5 1:12 AM | Daniella BeckmanChief Financial Officer | Grant/Award | 265,980 | $11.94 | 265,980(D) | View → |
| Feb 2, 2026 | Feb 5 1:09 AM | Barbara WeberDirector, Director, Executive Chair | Grant/Award | 222,132 | $11.94 | 222,132(D) | View → |
| Feb 2, 2026 | Feb 5 1:02 AM | Adam CrystalPresident, R&D | Grant/Award | 284,760 | $11.94 | 284,760(D) | View → |